Zomepirac

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C15H14ClNO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 822G987U9J, chemically known as 5-(4-chlorobenzoyl)-1,4-dimethyl-1h-pyrrole-2-acetic acid but generally known as zomepirac, which bears US NIH Compound Identifier 5733. European Medicines Agency schedules Zomepirac in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00185MIG. The term ZOMEPIRAC is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 31, No10, 1977, List 17). World Health Organization schedules zomepirac in its Anatomical Therapeutic Chemical (ATC) Classification. ZOMEPIRAC is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule zomepirac under HS 29339990 and SITC 51577. As of Q4 2014, ZOMEPIRAC remains the US FDA Preferred Term for this commodity. Zomepirac bears US NLM identifiers UMLS ID C0078840 and NCI Concept Code C66709. SMILES: CLC1CCC(C(=O)C2N(C(CC2C)CC(=O)O)C)CC1.